3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Neoplasm Metastasis
33
Leukemia, Myeloid, Acute
24
Melanoma
14
Colorectal Neoplasms
14
Breast Neoplasms
14
Multiple Myeloma
13
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Pancreatic Neoplasms
10
Lymphoma, Follicular
10
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Large B-Cell, Diffuse
8
Triple Negative Breast Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Lung Neoplasms
7
Burkitt Lymphoma
7
Ovarian Neoplasms
6
Lymphoma, B-Cell, Marginal Zone
6
Stomach Neoplasms
5
Sarcoma
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, T-Cell
5
Lymphoma, B-Cell
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Interventions
venetoclax
1
spartalizumab
1
sabatolimab
1
lintuzumab
1
fludarabine
1
Sertraline
1
Melphalan
1
Lenalidomide
1
Decitabine
1
Biopsy
1
Azacitidine
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Preleukemia
×
Biopsy
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled